KUKJEON PHARMACEUTICAL Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
KUKJEON PHARMACEUTICAL has a total shareholder equity of ₩99.9B and total debt of ₩73.6B, which brings its debt-to-equity ratio to 73.7%. Its total assets and total liabilities are ₩220.7B and ₩120.8B respectively. KUKJEON PHARMACEUTICAL's EBIT is ₩3.2B making its interest coverage ratio 0.5. It has cash and short-term investments of ₩52.4B.
Anahtar bilgiler
73.7%
Borç/özkaynak oranı
₩73.61b
Borç
| Faiz karşılama oranı | 0.5x |
| Nakit | ₩52.41b |
| Eşitlik | ₩99.86b |
| Toplam yükümlülükler | ₩120.84b |
| Toplam varlıklar | ₩220.70b |
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: A307750's short term assets (₩113.6B) exceed its short term liabilities (₩94.7B).
Uzun Vadeli Yükümlülükler: A307750's short term assets (₩113.6B) exceed its long term liabilities (₩26.1B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: A307750's net debt to equity ratio (21.2%) is considered satisfactory.
Borcun Azaltılması: Insufficient data to determine if A307750's debt to equity ratio has reduced over the past 5 years.
Borç Kapsamı: A307750's debt is not well covered by operating cash flow (11.4%).
Faiz Kapsamı: A307750's interest payments on its debt are not well covered by EBIT (0.5x coverage).